menu
    • menu

    Company profile for Adastra Pharmaceuticals

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adastra Pharmaceuticals Inc. is a private clinical-stage oncology company committed to providing responsible solutions to advance patient care in oncology. The Adastra lead clinical candidate, zotiraciclib, is initially being developed for the treatment of glioblastoma multiforme (GBM) and diffuse intrinsic pontine glioma (DIPG), two brain cancers characterized by Myc overexpression. Zotiraciclib is the subject of separate cli...
    Adastra Pharmaceuticals Inc. is a private clinical-stage oncology company committed to providing responsible solutions to advance patient care in oncology. The Adastra lead clinical candidate, zotiraciclib, is initially being developed for the treatment of glioblastoma multiforme (GBM) and diffuse intrinsic pontine glioma (DIPG), two brain cancers characterized by Myc overexpression. Zotiraciclib is the subject of separate clinical studies in GBM, as well as an upcoming pilot study in DIPG.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Adastra PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12481 High Bluff Drive Suite 150 San Diego, CA 92130
    Telephone
    Telephone
    (760) 208-6900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adastrarx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adastra Announces Lachlan McLeod As Interim CEO
    Adastra Announces Lachlan McLeod As Interim CEO

    15 Apr 2024

    // ACCESSWIRE

    https://www.accesswire.com/853287/adastra-holdings-announces-lachlan-mcleod-as-interim-ceo

    ACCESSWIRE
    15 Apr 2024
    Share Share
    Adastra Holdings Announces Record Single Purchase Order For Over $1M
    Adastra Holdings Announces Record Single Purchase Order For Over $1M

    01 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/838328/adastra-holdings-announces-record-single-purchase-order-for-over-1m

    ACCESSWIRE
    01 Mar 2024
    Share Share
    Adastra Holdings Announces Change of Auditor
    Adastra Holdings Announces Change of Auditor

    15 Dec 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=817630&lang=en

    ACCESSWIRE
    15 Dec 2023
    Share Share
    Adastra Provides Update Following Growup Awards Victory as Brand of The Year
    Adastra Provides Update Following Growup Awards Victory as Brand of The Year

    11 Oct 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=791776&lang=en

    ACCESSWIRE
    11 Oct 2023
    Share Share
    Adastra Holdings Receives Dual Nominations at 2023 Growup Awards and Gala
    Adastra Holdings Receives Dual Nominations at 2023 Growup Awards and Gala

    24 Aug 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=776859&lang=en

    ACCESSWIRE
    24 Aug 2023
    Share Share
    Adastra Holdings Reports Second Quarter Results
    Adastra Holdings Reports Second Quarter Results

    17 Aug 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=774777&lang=en

    ACCESSWIRE
    17 Aug 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search